Reflecting back on an incredible weekend - Duke Heart HF Symposium was a fantastic event with colleagues & friends. Kavita Sharma Kelly Schlendorf Marat Fudim, MD MHS Richa Agarwal Michael Felker Steve Greene Manesh Patel

Love the take from this review article on decongestion in acute heart failure.

Need to avoid de-escalating GDMT in acute HF to “make room” for decongestion. Loops exacerbate maladaptive neurohormonal abnormalities.

⬆️ GDMT
➕ loop diuretic

sciencedirect.com/science/articl…

Honored to be invited to the incredible Duke Heart Heart Failure Symposium this weekend! Fantastic, high-yield agenda of the latest in #heartfailure therapies - #GDMT , #HFpEF , #shock , HF #prevention and transplant. Congratulations to the organizers and faculty! Loved the…

Amazing Duke HF symposium this AM to standing room only audience Duke Heart Failure Duke Cardiology HFSA Robert Mentz, MD Kavita Sharma Marat Fudim, MD MHS Stephanie Barnes Steve Greene

Packed house at Duke Heart #HF Symposium!

Great speakers, great audience, all dedicated to improving outcomes for #HF

Richa Agarwal Marat Fudim, MD MHS Robert Mentz, MD Senthil Selvaraj, MD, MS, MA Kavita Sharma Ravi Karra Michael Felker Midge B DNP, FAANP, FAAN #GDMTworks

Duke HF symposium is off to a great start. Full house with biggest audience to date learning all about HF from an all-star faculty from Durham and beyond!

Duke Cardiology Duke University School of Medicine Duke Heart Failure Duke Clinical Research Institute Duke Surgery Duke Cardiology Fellows

Use of medical therapy and risk of clinical events according to frailty in #HeartFailure patients – A real-life cohort of Danish study

📌35,999 patients analyzed, showing lower HF therapy use in frail patients

📌Significant impact of frailty on clinical outcomes:
📍⬇️ use of HF…

So proud of ⭐️Duke Cardiology Fellows Dennis Narcisse! Congratulations!

💥💥 not long after #HeartFailureWeekCan May 5-11 comes #HFupdate May 24+25 🇨🇦+🌎🌍 of #heartfunction will be there REG at hfupdate.ca Justin Ezekowitz Anil Gupta Marco Metra Javed Butler Steve Greene Sean Virani Marc Bains Elizabeth Swiggum, MD BiykemBozkurt Jennifer Cowger…

American Heart Association Get With the Guidelines to be included in Cardiology & Heart Surgery specialty rankings by U.S. News & World Report #BestHospitals

Opportunity for national recognition for improving CV/stroke care and outcomes

Clyde Yancy, MD, MSc Robert Harrington Adrian “WE NEED RCTS!” Hernandez Dr. Deepak L. Bhatt Don Lloyd-Jones Jonathan Piccini, MD, MHS

🚨Stunning!🚨

REVERSAL in the decline of heart failure ☠️ in the US 1999-2021

1999-2005 ⬇️ ☠️
2005-2012 ⬇️ ☠️
2012-2019 ⬆️ ☠️
2019-2021 ⬆️⬆️☠️

Age-adjusted HF related ☠️ rates higher in 2021 vs 1999!

WT😱🆘

jamanetwork.com/journals/jamac…

JAMA Cardiology Marat Fudim, MD MHS

Impressive data on HFrEF: Although 82% of patients are eligible for quadruple therapy at discharge, only 15% actually receive it. This underutilization could significantly impact patient outcomes.

Gregg Fonarow MD JACC Journals American College of Cardiology Circulation European Society of Cardiology News

jacc.org/doi/10.1016/j.…

⚠️Eligibility and Projected Benefits of Rapid Initiation of Quadruple Medical 💊
for Newly Diagnosed #HF

👥 33036 🇺🇸newly diagnosed with HFrEF
👉82% were eligible for4️⃣💊,
👉93% were eligible for 3️⃣💊

⏰ 2021- 2023, of 👥 eligible for 4️⃣💊
▶️15.3% were prescribed 4️⃣💊
▶️41.5%…

We have to shift the acute care mindset beyond 'diurese & discharge' with ADHF. #GDMT saves lives and we must strive to get patients on quadruple therapy while hospitalized

Bailey Ann Estes Viet Le DMSc PA-C FACC FAHA HF-Cert Andrea Price, RCIS, CPHQ, AACC Derek Pineda Gregg Fonarow MD Steve Greene

Check out our review on 'SGLT2i and GU infections' in JACC Journals

🔗: shorturl.at/gsGL7

Here we discuss
- SGLT2i mechanisms/benefits
- Trial/real-world evidence of SGLT2i/GU ifx
- Risk factors
- Practice considerations

🧵 to follow (1/5)

ICYMI: In our #ACC24 episode of #DontMissABeat , Javed Butler joined @SJGreene_MD and @MVaduganathan to discuss EMPACT-MI.

#Cardiology #HeartFailure

hcplive.com/view/don-t-mis…

Proud of our chief fellow Duke Cardiology Fellows Joe Lerman, MD and future Duke Heart Failure fellow for his excellent presentation of impact of UNOS allocation on PGD ❤️💙!!

The ISHLT Duke Clinical Research Institute Richa Agarwal Adam DeVore, MD, MHS Robert Mentz, MD Manesh Patel

Jacob Niall Schroder Speaking The ISHLT on Real World Clinical Outcomes of DCD Heart Transplantation from the OCS Heart Perfusion Registry: Benchmarking to Other Preservation Methods Duke Heart Duke Surgery Duke Heart Failure Adam DeVore, MD, MHS Richa Agarwal

Hospital costs for those with #HFrEF tend to be high – yet the factors that contribute to these costs vary. DCRI Fellow Mark Kittipibul MD sat down with HCPLive at #ACC24 to discuss the GWTG-HF registry, and how to reduce HF-related costs: hcplive.com/view/understan…

Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2i

👥146,003
📌34.7% EF≤40%
📌65.3% EF>40%
💰Mean total cost through 1-year was $40,557
👥EF>40% had higher costs due to non-HF and non-CV🏥
🧮5 SGLT2i clinical trials…